Stomatitis News and Research

RSS
Highly diluted candidate Ebola vaccine remains fully protective against disease in macaques

Highly diluted candidate Ebola vaccine remains fully protective against disease in macaques

Scientists show how the immune system reacts to Ebola vaccine

Scientists show how the immune system reacts to Ebola vaccine

CRISPR RNA-cutting enzyme programmed to destroy viruses in human cells

CRISPR RNA-cutting enzyme programmed to destroy viruses in human cells

Scientists develop universal FACS-based approach to heterogenous cell sorting, propelling organoid research

Scientists develop universal FACS-based approach to heterogenous cell sorting, propelling organoid research

Starving the fungus could help fight drug-resistant fungal infections

Starving the fungus could help fight drug-resistant fungal infections

FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

Viruses behave altruistically to avoid the immune system, study shows

Viruses behave altruistically to avoid the immune system, study shows

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Unique experimental vaccine against Zika virus proves powerful in mice

Unique experimental vaccine against Zika virus proves powerful in mice

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Unique patch could revolutionize treatment of painful recurring ulcers

Unique patch could revolutionize treatment of painful recurring ulcers

UB researchers build 3D-printed, drug-filled dentures to fight against infections

UB researchers build 3D-printed, drug-filled dentures to fight against infections

FDA grants approval for first drug to treat inherited breast cancer

FDA grants approval for first drug to treat inherited breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers